Tetrasomy of Philadelphia chromosome in myeloblastic crisis of chronic myelogenous leukemia.
H
H
Oikawa
T
T
Utsugisawa
K
K
Murai
Y
Y
Narigasawa
Y
Y
Miyairi
K
K
Shimosegawa
T
T
Suzuki
S
S
Kuriya
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001752:Blast Crisis / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D017809:Fatal Outcome; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000473:pathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010677:Philadelphia Chromosome; D011994:Recombinant Proteins; D012074:Remission Induction
D007155:Immunologic Factors; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D006918:Hydroxyurea